Rosabella Moringa Powder Capsules Recalled Due to Salmonella Outbreak

FDA issues nationwide recall for specific lot codes of the dietary supplement linked to illnesses across 7 states.

Published on Feb. 20, 2026

The U.S. Food and Drug Administration (FDA) has issued a nationwide recall for Rosabella brand moringa powder capsules due to potential Salmonella contamination. The recall affects specific lot codes with expiration dates through November 2027, which were distributed through various online retailers. As of February 17, 2026, seven illnesses have been reported across seven states, with three hospitalizations linked to the contaminated capsules.

Why it matters

This recall highlights the ongoing challenges with ensuring the safety and quality of dietary supplements, which are subject to less stringent regulations than traditional pharmaceuticals. The discovery of an extensively drug-resistant strain of Salmonella linked to these capsules adds another layer of concern, as drug-resistant infections can be difficult to treat.

The details

The recalled Rosabella moringa capsules were distributed nationwide through several online retailers, including eBay, TikTok Shop, Amazon, Shein, and the company's direct-to-consumer website, Tryrosabella.com. Lot codes start with '1356' and range from 5020591 through 5100048. Consumers are urged to check the bottom of their bottles to identify if they have an affected lot. Salmonella infection can cause a range of symptoms, including diarrhea, stomach cramps, headaches, nausea, vomiting, and loss of appetite.

  • As of February 17, 2026, seven illnesses have been reported across seven states – Arizona, Florida, Iowa, Illinois, Indiana, Tennessee, and Washington – with three hospitalizations linked to the contaminated capsules.

The players

Rosabella

A brand of moringa powder capsules that has been recalled due to potential Salmonella contamination.

U.S. Food and Drug Administration (FDA)

The federal agency that issued the nationwide recall for the Rosabella moringa capsules.

Got photos? Submit your photos here. ›

What’s next

The FDA is investigating an extensively drug-resistant strain of Salmonella linked to these capsules, which could pose additional challenges for treatment.

The takeaway

This recall underscores the importance of increased regulation and oversight in the dietary supplement industry to ensure the safety and quality of these products, especially as concerns around drug-resistant infections continue to grow.